Business Description
BRAIN Biotech AG
ISIN : DE0005203947
Compare
Compare
Traded in other countries / regions
BNN.Germany0RFI.UK IPO Date
2016-02-09Description
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.29 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -2.52 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.47 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.3 | |||||
| 3-Year EBITDA Growth Rate | 30.1 | |||||
| 3-Year EPS without NRI Growth Rate | 10.2 | |||||
| 3-Year FCF Growth Rate | 8.4 | |||||
| 3-Year Book Growth Rate | -1.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 25.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.25 | |||||
| 9-Day RSI | 33.07 | |||||
| 14-Day RSI | 31.66 | |||||
| 6-1 Month Momentum % | -4.83 | |||||
| 12-1 Month Momentum % | -40.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.64 | |||||
| Days Inventory | 145.69 | |||||
| Days Sales Outstanding | 55.32 | |||||
| Days Payable | 83.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | -2.63 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.43 | |||||
| Operating Margin % | -10.61 | |||||
| Net Margin % | -15.44 | |||||
| FCF Margin % | -8.87 | |||||
| ROE % | -36.03 | |||||
| ROA % | -11.76 | |||||
| ROIC % | -9.33 | |||||
| ROC (Joel Greenblatt) % | -36.05 | |||||
| ROCE % | -12.11 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.16 | |||||
| PB Ratio | 3.27 | |||||
| Price-to-Tangible-Book | 3.16 | |||||
| EV-to-EBIT | -9.26 | |||||
| EV-to-EBITDA | -32.89 | |||||
| EV-to-Revenue | 1.12 | |||||
| EV-to-FCF | -12.9 | |||||
| Earnings Yield (Greenblatt) % | -10.81 | |||||
| FCF Yield % | -7.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BRAIN Biotech AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 54.37 | ||
| EPS (TTM) (€) | -0.38 | ||
| Beta | 1.62 | ||
| Volatility % | 40.16 | ||
| 14-Day RSI | 31.66 | ||
| 14-Day ATR (€) | 0.199482 | ||
| 20-Day SMA (€) | 2.9415 | ||
| 12-1 Month Momentum % | -40.39 | ||
| 52-Week Range (€) | 2.51 - 5.62 | ||
| Shares Outstanding (Mil) | 21.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BRAIN Biotech AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BRAIN Biotech AG Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BRAIN Biotech AG Frequently Asked Questions
What is BRAIN Biotech AG(XTER:BNN)'s stock price today?
The current price of XTER:BNN is €2.78. The 52 week high of XTER:BNN is €5.62 and 52 week low is €2.51.
When is next earnings date of BRAIN Biotech AG(XTER:BNN)?
The next earnings date of BRAIN Biotech AG(XTER:BNN) is .
Does BRAIN Biotech AG(XTER:BNN) pay dividends? If so, how much?
BRAIN Biotech AG(XTER:BNN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers